Search results
Found 30886 matches for
New research from Dr Richard Williams’ group at the Kennedy Institute suggests a route for the development of more selective – and effective – therapies for immune-mediated inflammatory disease.
OCTRU Training Bite: Audit Findings from 2025 *online*
Thursday, 01 January 2026, 10am to 11am
OCTRU Training Bite: Common findings from OCTRU Sponsor Package Reviews, DM12 reviews and database builds *online*
Thursday, 01 January 2026, 10am to 11am
OCTRU Training Bite: Trial Closure and Archiving *online*
Thursday, 01 January 2026, 10am to 11am
OCTRU Training Bite: SIMS Overview - Basic configuration (from tmt perspective what DBO do) PJ/Simon to confirm title *online*
Thursday, 01 January 2026, 10am to 11am
OCTRU Training Bite: Safety Oversight and Reporting *online*
Thursday, 01 January 2026, 10am to 11am
OCTRU Training Bite: Grant Development and Costing for Trial Managers - what needs to go in *online*
Thursday, 01 January 2026, 10am to 11am
OCTRU Training Bite: Patient Information Sheets (PIS): Development of good PIS *online*
Thursday, 01 January 2026, 10am to 11am
OCTRU Training Bite: Classification of Trials *online*
Thursday, 01 January 2026, 10am to 11am
OCTRU Training Bite: Management of IMP and Relevant Documentation *online*
Thursday, 01 January 2026, 10am to 11am
OCTRU Extended Training Bite: Risk Assessment and Monitoring Plans *online*
Thursday, 01 January 2026, 10am to 11am
OCTRU Extended Training Bite: Statistics for Non Statisticians *online*
Thursday, 01 January 2026, 10am to 11am
OCTRU Extended Training Bite: Introduction to the Trial Master File (TMF) *online*
Thursday, 01 January 2026, 10am to 11am
Meet the team
-
I-Shu Huang
Postdoctoral Researcher
-
Felix Clanchy
Senior Postdoctoral Researcher
-
Sir Marc Feldmann FRS
Emeritus Professor
-
Richard Williams
Professor
TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells
Find out more about
Similar stories
Two NDORMS groups join the PROBE Initiative to advance osteoarthritis research
5 December 2025
Two research groups at NDORMS have joined the newly launched PROBE initiative, contributing their expertise to a major European collaboration focused on improving the understanding, diagnosis and treatment of osteoarthritis.